Introduction:: Diabetes is a major global health challenge that continues to grow at an alarming rate, demanding novel and effective therapeutic strategies. While allopathic drugs such as metformin and insulin effectively control blood glucose, they are associated with longterm side effects. Herbal therapies, rich in phytochemicals such as curcumin, berberine, and gymnemic acid, offer safer alternatives. Nanotechnology has emerged as a promising approach to enhance the bioavailability, stability, and targeted delivery of both drug types. Methods:: A comprehensive literature review was conducted using PubMed, Scopus, Web of Science, Google Scholar, and ClinicalTrials.gov. Studies comparing the efficacy, safety, and delivery characteristics of herbal and allopathic antidiabetic nanoformulations were critically evaluated. Results:: Herbal nanoformulations demonstrated potent hypoglycemic, antioxidant, and antiinflammatory activities with minimal toxicity. Nanoencapsulation of phytoconstituents significantly improved their solubility and pharmacokinetics. Allopathic nanoformulations, including insulin and metformin nanoparticles, exhibited enhanced pharmacodynamic responses, controlled release, and improved patient compliance, but carried higher costs and potential biocompatibility concerns. Direct comparative studies between the two systems, however, remain limited. Discussion:: Integrating nanotechnology with herbal and allopathic therapies can address the limitations of conventional antidiabetic drugs. Such synergy may enhance therapeutic outcomes through improved targeting, reduced toxicity, and prolonged activity. Conclusion:: The future of diabetes therapy lies in integrating herbal and allopathic nanoformulations, combining the curative wisdom of traditional medicine with the precision and efficacy of modern pharmaceutical science.
Saini et al. (Thu,) studied this question.